Structure

Physi-Chem Properties

Molecular Weight:  424.19
Volume:  444.3
LogP:  5.688
LogD:  3.674
LogS:  -2.72
# Rotatable Bonds:  5
TPSA:  107.22
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.527
Synthetic Accessibility Score:  3.863
Fsp3:  0.32
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.937
MDCK Permeability:  1.313045959250303e-05
Pgp-inhibitor:  0.631
Pgp-substrate:  0.118
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.939
30% Bioavailability (F30%):  0.165

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.008
Plasma Protein Binding (PPB):  95.67901611328125%
Volume Distribution (VD):  0.691
Pgp-substrate:  4.549530982971191%

ADMET: Metabolism

CYP1A2-inhibitor:  0.193
CYP1A2-substrate:  0.169
CYP2C19-inhibitor:  0.684
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.862
CYP2C9-substrate:  0.901
CYP2D6-inhibitor:  0.934
CYP2D6-substrate:  0.27
CYP3A4-inhibitor:  0.389
CYP3A4-substrate:  0.162

ADMET: Excretion

Clearance (CL):  10.453
Half-life (T1/2):  0.16

ADMET: Toxicity

hERG Blockers:  0.031
Human Hepatotoxicity (H-HT):  0.423
Drug-inuced Liver Injury (DILI):  0.859
AMES Toxicity:  0.058
Rat Oral Acute Toxicity:  0.269
Maximum Recommended Daily Dose:  0.087
Skin Sensitization:  0.83
Carcinogencity:  0.056
Eye Corrosion:  0.003
Eye Irritation:  0.416
Respiratory Toxicity:  0.112

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC278476

Natural Product ID:  NPC278476
Common Name*:   (2R,3R)-Lespedezaflavanone C
IUPAC Name:   (2R,3R)-3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
Synonyms:   (2R,3R)-Lespedezaflavanone C
Standard InCHIKey:  WFHBGCVPESHDKZ-BJKOFHAPSA-N
Standard InCHI:  InChI=1S/C25H28O6/c1-13(2)5-7-15-11-16(8-10-18(15)26)24-23(30)22(29)21-20(28)12-19(27)17(25(21)31-24)9-6-14(3)4/h5-6,8,10-12,23-24,26-28,30H,7,9H2,1-4H3/t23-,24+/m0/s1
SMILES:  CC(=CCc1cc(ccc1O)[C@@H]1[C@H](C(=O)c2c(cc(c(CC=C(C)C)c2O1)O)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL463256
PubChem CID:   14542252
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0000337] Flavans
          • [CHEMONTID:0003642] 8-prenylated flavans
            • [CHEMONTID:0003508] 8-prenylated flavanones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. root n.a. PMID[11395279]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota whole plants n.a. n.a. PMID[11678652]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota whole plants Shawnee National Forest, Harrisburg, IL, US n.a. PMID[11678652]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. PMID[12419367]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota leaves Kaohsiung, Taiwan 2006-SEP PMID[18986201]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota Fruits n.a. n.a. PMID[19296617]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. formosan n.a. PMID[8864236]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. PMID[9358644]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT441 Individual Protein Cytochrome P450 19A1 Homo sapiens IC50 > 40.0 ug.mL-1 PMID[571185]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC278476 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC254412
1.0 High Similarity NPC262039
1.0 High Similarity NPC319910
1.0 High Similarity NPC262038
0.9931 High Similarity NPC105136
0.9931 High Similarity NPC35567
0.9931 High Similarity NPC216035
0.9931 High Similarity NPC171651
0.9931 High Similarity NPC243171
0.9931 High Similarity NPC217149
0.9931 High Similarity NPC138288
0.9863 High Similarity NPC293286
0.9796 High Similarity NPC304207
0.9796 High Similarity NPC111341
0.9796 High Similarity NPC48579
0.9796 High Similarity NPC207809
0.9796 High Similarity NPC217706
0.9796 High Similarity NPC304745
0.9796 High Similarity NPC259710
0.973 High Similarity NPC215917
0.973 High Similarity NPC10754
0.973 High Similarity NPC20530
0.9728 High Similarity NPC244250
0.9728 High Similarity NPC248793
0.9728 High Similarity NPC268193
0.9728 High Similarity NPC20907
0.9728 High Similarity NPC180301
0.9726 High Similarity NPC471677
0.9726 High Similarity NPC263384
0.9726 High Similarity NPC472420
0.9726 High Similarity NPC472422
0.9726 High Similarity NPC471676
0.9726 High Similarity NPC244577
0.9722 High Similarity NPC476182
0.9722 High Similarity NPC40086
0.9722 High Similarity NPC44721
0.9722 High Similarity NPC211466
0.9722 High Similarity NPC176869
0.9722 High Similarity NPC3779
0.9722 High Similarity NPC122828
0.966 High Similarity NPC161881
0.966 High Similarity NPC10807
0.966 High Similarity NPC56232
0.966 High Similarity NPC150123
0.966 High Similarity NPC244583
0.966 High Similarity NPC210597
0.966 High Similarity NPC475790
0.9653 High Similarity NPC472629
0.96 High Similarity NPC22192
0.9595 High Similarity NPC472583
0.9595 High Similarity NPC7989
0.9595 High Similarity NPC100134
0.9595 High Similarity NPC209760
0.9595 High Similarity NPC236756
0.9595 High Similarity NPC311579
0.9595 High Similarity NPC223701
0.9592 High Similarity NPC472636
0.9592 High Similarity NPC328740
0.9592 High Similarity NPC289774
0.9592 High Similarity NPC209846
0.9592 High Similarity NPC477897
0.9592 High Similarity NPC474021
0.9592 High Similarity NPC474023
0.9589 High Similarity NPC472628
0.9589 High Similarity NPC89442
0.9586 High Similarity NPC472918
0.9586 High Similarity NPC472627
0.9583 High Similarity NPC279417
0.9583 High Similarity NPC470890
0.9583 High Similarity NPC49130
0.9583 High Similarity NPC326506
0.9583 High Similarity NPC142731
0.9583 High Similarity NPC124780
0.9583 High Similarity NPC306607
0.9583 High Similarity NPC62290
0.9583 High Similarity NPC87486
0.9583 High Similarity NPC4152
0.9583 High Similarity NPC208176
0.9536 High Similarity NPC282009
0.9536 High Similarity NPC287328
0.953 High Similarity NPC476169
0.953 High Similarity NPC471116
0.953 High Similarity NPC477958
0.9527 High Similarity NPC473996
0.9524 High Similarity NPC61258
0.9521 High Similarity NPC218569
0.9521 High Similarity NPC10097
0.9517 High Similarity NPC148011
0.9517 High Similarity NPC1940
0.9474 High Similarity NPC471499
0.947 High Similarity NPC123544
0.9467 High Similarity NPC78492
0.9467 High Similarity NPC208152
0.9463 High Similarity NPC112701
0.9463 High Similarity NPC88983
0.9463 High Similarity NPC326592
0.9463 High Similarity NPC469405
0.9463 High Similarity NPC109594
0.9459 High Similarity NPC474772
0.9459 High Similarity NPC474744
0.9459 High Similarity NPC472423
0.9459 High Similarity NPC472580
0.9459 High Similarity NPC471229
0.9459 High Similarity NPC471675
0.9456 High Similarity NPC277032
0.9456 High Similarity NPC470461
0.9456 High Similarity NPC307052
0.9456 High Similarity NPC139966
0.9452 High Similarity NPC47388
0.9452 High Similarity NPC21835
0.9452 High Similarity NPC470670
0.9452 High Similarity NPC473133
0.9452 High Similarity NPC85773
0.9452 High Similarity NPC91902
0.9448 High Similarity NPC273538
0.9448 High Similarity NPC216538
0.9448 High Similarity NPC224714
0.9444 High Similarity NPC66515
0.9444 High Similarity NPC296917
0.9444 High Similarity NPC306829
0.9444 High Similarity NPC32739
0.9444 High Similarity NPC76372
0.9444 High Similarity NPC107572
0.9444 High Similarity NPC324134
0.9444 High Similarity NPC166934
0.9444 High Similarity NPC324436
0.9444 High Similarity NPC194432
0.9444 High Similarity NPC161506
0.9444 High Similarity NPC265040
0.9444 High Similarity NPC227579
0.9444 High Similarity NPC37496
0.9444 High Similarity NPC167624
0.9444 High Similarity NPC228504
0.9444 High Similarity NPC220998
0.9444 High Similarity NPC76338
0.9444 High Similarity NPC78
0.9444 High Similarity NPC166482
0.9444 High Similarity NPC223500
0.9444 High Similarity NPC10937
0.9444 High Similarity NPC177354
0.9444 High Similarity NPC40833
0.9444 High Similarity NPC64915
0.9444 High Similarity NPC328164
0.9444 High Similarity NPC182852
0.9444 High Similarity NPC1089
0.9444 High Similarity NPC125855
0.9444 High Similarity NPC148757
0.9412 High Similarity NPC131745
0.9412 High Similarity NPC259834
0.9408 High Similarity NPC470326
0.9408 High Similarity NPC306978
0.9404 High Similarity NPC474055
0.9404 High Similarity NPC472598
0.94 High Similarity NPC321779
0.94 High Similarity NPC470681
0.9396 High Similarity NPC285623
0.9396 High Similarity NPC327269
0.9396 High Similarity NPC477957
0.9396 High Similarity NPC476238
0.9396 High Similarity NPC31627
0.9392 High Similarity NPC124478
0.9392 High Similarity NPC177308
0.9392 High Similarity NPC472421
0.9392 High Similarity NPC267117
0.9388 High Similarity NPC470460
0.9388 High Similarity NPC296869
0.9384 High Similarity NPC290133
0.9384 High Similarity NPC5820
0.9384 High Similarity NPC316769
0.9384 High Similarity NPC187282
0.9384 High Similarity NPC474302
0.9384 High Similarity NPC470458
0.9384 High Similarity NPC229190
0.9384 High Similarity NPC124729
0.9384 High Similarity NPC306488
0.9384 High Similarity NPC24136
0.9384 High Similarity NPC178343
0.9379 High Similarity NPC149026
0.9379 High Similarity NPC310130
0.9379 High Similarity NPC257097
0.9379 High Similarity NPC81697
0.9379 High Similarity NPC85162
0.9379 High Similarity NPC150408
0.9379 High Similarity NPC68104
0.9379 High Similarity NPC9117
0.9379 High Similarity NPC278249
0.9379 High Similarity NPC143896
0.9379 High Similarity NPC190637
0.9379 High Similarity NPC24821
0.9379 High Similarity NPC185276
0.9379 High Similarity NPC212932
0.9379 High Similarity NPC301751
0.9379 High Similarity NPC214166
0.9379 High Similarity NPC175504
0.9379 High Similarity NPC478086
0.9379 High Similarity NPC75049
0.9379 High Similarity NPC221432
0.9379 High Similarity NPC91560
0.9379 High Similarity NPC125894
0.9379 High Similarity NPC107177

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC278476 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9448 High Similarity NPD4378 Clinical (unspecified phase)
0.9404 High Similarity NPD7075 Discontinued
0.9392 High Similarity NPD4380 Phase 2
0.9333 High Similarity NPD7096 Clinical (unspecified phase)
0.9333 High Similarity NPD2393 Clinical (unspecified phase)
0.9139 High Similarity NPD6801 Discontinued
0.9139 High Similarity NPD1934 Approved
0.9114 High Similarity NPD7804 Clinical (unspecified phase)
0.9097 High Similarity NPD1552 Clinical (unspecified phase)
0.9097 High Similarity NPD1550 Clinical (unspecified phase)
0.9045 High Similarity NPD6168 Clinical (unspecified phase)
0.9045 High Similarity NPD6167 Clinical (unspecified phase)
0.9045 High Similarity NPD6166 Phase 2
0.9034 High Similarity NPD1549 Phase 2
0.9026 High Similarity NPD4381 Clinical (unspecified phase)
0.8896 High Similarity NPD8443 Clinical (unspecified phase)
0.8859 High Similarity NPD6799 Approved
0.8767 High Similarity NPD2796 Approved
0.8742 High Similarity NPD1512 Approved
0.8718 High Similarity NPD3882 Suspended
0.871 High Similarity NPD2801 Approved
0.8701 High Similarity NPD7411 Suspended
0.8699 High Similarity NPD1510 Phase 2
0.8675 High Similarity NPD7410 Clinical (unspecified phase)
0.8654 High Similarity NPD3817 Phase 2
0.865 High Similarity NPD6797 Phase 2
0.8636 High Similarity NPD6599 Discontinued
0.8609 High Similarity NPD1511 Approved
0.8598 High Similarity NPD7251 Discontinued
0.859 High Similarity NPD7819 Suspended
0.8589 High Similarity NPD7074 Phase 3
0.8562 High Similarity NPD5403 Approved
0.8552 High Similarity NPD1240 Approved
0.8545 High Similarity NPD7808 Phase 3
0.8528 High Similarity NPD7054 Approved
0.85 High Similarity NPD6959 Discontinued
0.8485 Intermediate Similarity NPD6559 Discontinued
0.8476 Intermediate Similarity NPD7472 Approved
0.8466 Intermediate Similarity NPD3818 Discontinued
0.8438 Intermediate Similarity NPD5494 Approved
0.8435 Intermediate Similarity NPD1607 Approved
0.8434 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8431 Intermediate Similarity NPD5401 Approved
0.8418 Intermediate Similarity NPD5402 Approved
0.8365 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.825 Intermediate Similarity NPD7768 Phase 2
0.8224 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8224 Intermediate Similarity NPD2800 Approved
0.8204 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD5844 Phase 1
0.817 Intermediate Similarity NPD4628 Phase 3
0.811 Intermediate Similarity NPD6232 Discontinued
0.8072 Intermediate Similarity NPD7473 Discontinued
0.8052 Intermediate Similarity NPD3750 Approved
0.8041 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD1551 Phase 2
0.8026 Intermediate Similarity NPD2935 Discontinued
0.8 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD3749 Approved
0.7975 Intermediate Similarity NPD920 Approved
0.7966 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD2534 Approved
0.7962 Intermediate Similarity NPD2533 Approved
0.7962 Intermediate Similarity NPD2532 Approved
0.7947 Intermediate Similarity NPD6651 Approved
0.7943 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD1247 Approved
0.7933 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD1613 Approved
0.7927 Intermediate Similarity NPD919 Approved
0.7922 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD5953 Discontinued
0.7871 Intermediate Similarity NPD1243 Approved
0.787 Intermediate Similarity NPD7286 Phase 2
0.7853 Intermediate Similarity NPD4363 Phase 3
0.7853 Intermediate Similarity NPD4360 Phase 2
0.7848 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7843 Intermediate Similarity NPD2799 Discontinued
0.7834 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7811 Intermediate Similarity NPD3751 Discontinued
0.78 Intermediate Similarity NPD2313 Discontinued
0.78 Intermediate Similarity NPD6798 Discontinued
0.7793 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD4908 Phase 1
0.7784 Intermediate Similarity NPD3787 Discontinued
0.7742 Intermediate Similarity NPD2344 Approved
0.7738 Intermediate Similarity NPD3926 Phase 2
0.7727 Intermediate Similarity NPD3748 Approved
0.7727 Intermediate Similarity NPD7033 Discontinued
0.7697 Intermediate Similarity NPD943 Approved
0.7692 Intermediate Similarity NPD2424 Discontinued
0.7683 Intermediate Similarity NPD1465 Phase 2
0.7677 Intermediate Similarity NPD6100 Approved
0.7677 Intermediate Similarity NPD6099 Approved
0.7676 Intermediate Similarity NPD7584 Approved
0.7671 Intermediate Similarity NPD1610 Phase 2
0.7669 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD3226 Approved
0.7647 Intermediate Similarity NPD5124 Phase 1
0.7647 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD6355 Discontinued
0.7644 Intermediate Similarity NPD8312 Approved
0.7644 Intermediate Similarity NPD8313 Approved
0.7637 Intermediate Similarity NPD6782 Approved
0.7637 Intermediate Similarity NPD6778 Approved
0.7637 Intermediate Similarity NPD6777 Approved
0.7637 Intermediate Similarity NPD6776 Approved
0.7637 Intermediate Similarity NPD6781 Approved
0.7637 Intermediate Similarity NPD6779 Approved
0.7637 Intermediate Similarity NPD6780 Approved
0.7632 Intermediate Similarity NPD6233 Phase 2
0.7628 Intermediate Similarity NPD2346 Discontinued
0.7616 Intermediate Similarity NPD3027 Phase 3
0.7614 Intermediate Similarity NPD8434 Phase 2
0.7613 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD1203 Approved
0.7576 Intermediate Similarity NPD8455 Phase 2
0.7562 Intermediate Similarity NPD7390 Discontinued
0.755 Intermediate Similarity NPD6832 Phase 2
0.7547 Intermediate Similarity NPD2309 Approved
0.7532 Intermediate Similarity NPD1652 Phase 2
0.7517 Intermediate Similarity NPD1548 Phase 1
0.7516 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD8150 Discontinued
0.7514 Intermediate Similarity NPD7435 Discontinued
0.7514 Intermediate Similarity NPD4361 Phase 2
0.7514 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD5710 Approved
0.7471 Intermediate Similarity NPD5711 Approved
0.7471 Intermediate Similarity NPD3823 Discontinued
0.7468 Intermediate Similarity NPD4060 Phase 1
0.7451 Intermediate Similarity NPD3268 Approved
0.7446 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD7458 Discontinued
0.7439 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD6190 Approved
0.7427 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD7698 Approved
0.7419 Intermediate Similarity NPD7697 Approved
0.7419 Intermediate Similarity NPD7696 Phase 3
0.7419 Intermediate Similarity NPD1933 Approved
0.7419 Intermediate Similarity NPD230 Phase 1
0.7417 Intermediate Similarity NPD2798 Approved
0.7412 Intermediate Similarity NPD7199 Phase 2
0.7407 Intermediate Similarity NPD4662 Approved
0.7407 Intermediate Similarity NPD4661 Approved
0.7389 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD4625 Phase 3
0.7384 Intermediate Similarity NPD2403 Approved
0.7384 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD9717 Approved
0.738 Intermediate Similarity NPD7871 Phase 2
0.738 Intermediate Similarity NPD7870 Phase 2
0.7363 Intermediate Similarity NPD6535 Approved
0.7363 Intermediate Similarity NPD6534 Approved
0.7362 Intermediate Similarity NPD5049 Phase 3
0.736 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7354 Intermediate Similarity NPD7701 Phase 2
0.7351 Intermediate Similarity NPD2797 Approved
0.7333 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD3887 Approved
0.7329 Intermediate Similarity NPD2354 Approved
0.7325 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD4536 Approved
0.7325 Intermediate Similarity NPD4538 Approved
0.7316 Intermediate Similarity NPD8151 Discontinued
0.7315 Intermediate Similarity NPD422 Phase 1
0.7314 Intermediate Similarity NPD1729 Discontinued
0.7312 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD2654 Approved
0.7308 Intermediate Similarity NPD447 Suspended
0.7308 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD6844 Discontinued
0.7305 Intermediate Similarity NPD37 Approved
0.7294 Intermediate Similarity NPD6234 Discontinued
0.729 Intermediate Similarity NPD4062 Phase 3
0.7283 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD4967 Phase 2
0.7278 Intermediate Similarity NPD4965 Approved
0.7278 Intermediate Similarity NPD4308 Phase 3
0.7278 Intermediate Similarity NPD4966 Approved
0.7277 Intermediate Similarity NPD7874 Approved
0.7277 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD1653 Approved
0.7267 Intermediate Similarity NPD7229 Phase 3
0.7263 Intermediate Similarity NPD7585 Approved
0.7255 Intermediate Similarity NPD2861 Phase 2
0.7243 Intermediate Similarity NPD7699 Phase 2
0.7243 Intermediate Similarity NPD7700 Phase 2
0.724 Intermediate Similarity NPD7783 Phase 2
0.724 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.724 Intermediate Similarity NPD7801 Approved
0.7239 Intermediate Similarity NPD6143 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data